CEO John Lewis, COO Catalina Vasquez, and CCO Colin Coros are in San Francisco Jan 13 to 16 for JPM Week. Meet up with them to talk about our lead diagnostic product ClarityDX Prostate. This novel blood test is currently being validated in a clinical study with men recruited from Alberta, Yukon, and Florida. Click on the "Abstract" button below to read:
Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically Significant Prostate Cancer
Catalina Vasquez and Colin Coros were interviewed by Bryce Lambert on Alberta Impact. They talked about how and why the Alberta Prostate Cancer Research Initiative came to be-thanks to Frank Sojonky and the Bird Dogs, Nanostics as a UofA spinoff company aimed at translating bench results to the clinic, the ClarityDX Prostate test for early diagnosis of aggressive prostate cancer, and the ongoing, Alberta-based clinical study to validate the test in a real-world setting, at DynaLIFE. Click on "address" to go to the show!
Nanostics was pleased to co-sponsor, along with AWSN, the 2019 Women in Science, Engineering & Research (WiSER) annual family BBQ. WiSER mentors and promotes women entering into STEM fields and men in non-traditional STEM fields. We had a great day of science crafts, food, prizes, and conversation!